Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9

10:13 EDT 11 May 2018 | Nature Publishing

More From BioPortfolio on "Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9"